Nevertheless, the rise in the Statutory Scheme rate to almost a third of pharma company revenue – which brings the average ...

The 5th Medical Device Software Development Summit is your must-attend opportunity to gain actionable strategies, real-world ...

According to Prof Phil Banfield, chair of the BMA council, it had become clear that the centre "no longer has a grip on the ...

The Vaccines and Related Biological Products Advisory Committee (VRBPAC) had been scheduled to meet to discuss the strains ...

Jane Chung, president and chief operating officer at Sutro, is replacing Bill Newell as chief executive as the company starts ...

According to Prof Phil Banfield, chair of BMA council, it had become clear that the centre "no longer has a grip on the ...

Philadelphia-based Endo sold its international pharma unit to Knight Therapeutics this week for up to $99 million, while ...

New data from the phase 3 MINT trial in adults living with autoimmune disorder generalised myasthenia gravis (gMG) – which ...

Just days after announcing sweeping job cuts at NHS England, UK Prime Minister Keir Starmer has said that the government ...

President Donald Trump has withdrawn his nomination of Dave Weldon to lead the CDC, just hours before he was due to appear in ...

Roche has parted with $1.4 billion upfront to secure rights to an obesity candidate developed by Zealand Pharma, taking its ...

The list price of Mavenclad is around £2,050 per 10mg tablet, although, Merck is providing it to the NHS in England at a ...